|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication June 3, 2004.
Revised September 10, 2004.
Accepted for publication September 16, 2004.
Protein kinase C isoforms are important transducers of signals from G protein-coupled receptors (GPCRs) to diverse cellular targets, including extracellularly signal regulated kinases 1 and 2 (ERK1/2). Clone 9 rat hepatocytes (C9 cells) express receptors for angiotensin II (Ang II) type 1 (AT1-R), lysophosphatidic acid (LPA) and epidermal growth factor (EGF), and their stimulation causes transient ERK1/2 phosphorylation through transactivation of the EGF-R. Inhibition of PKC by Go6983, or PKC depletion by prolonged PMA treatment, attenuated ERK1/2 activation by Ang II and PMA, but not by LPA and EGF. In contrast, another PKC inhibitor, Go6976, enhanced basal and agonist-stimulated phosphorylation of ERK1/2, which was not due to alteration in receptor binding and internalization, stimulation of inositol phosphate production, or activation of Pyk2 and Src tyrosine kinases. However, Go6976 enhanced agonist-induced tyrosine phosphorylation of the EGF-receptor, possibly through inhibition of protein tyrosine phosphatase (PTP), since the PTP inhibitor, sodium orthovanadate, mimicked the effects of Go6976. Selective blockade of EGF-R kinase by AG1478 abolished the ERK1/2 activation induced by Go6976. Similar experiments were conducted in HEK293 cells, which express receptors for LPA and EGF but exhibit no significant cross-communication between them. While Go6976 caused a significant increase in EGF-induced tyrosine phosphorylation of the EGF-R and subsequent ERK1/2 activation, it had no such effects on LPA-induced responses. In CHO cells, which express receptors for LPA but not for EGF, Go6976 also had no significant effect on LPA-induced ERK1/2 activation. These data indicate that Go6976 potentiates agonist-induced ERK1/2 activation through stimulation of tyrosine phosphorylation of the EGF-R.
Key words:
Angiotensin, NGF/EGF, Gq/11 family, Protein tyr Phosphatases, Phosphorylation/Dephosphorylation, MAP Kinase
This article has been cited by other articles:
![]() |
C.-M. Yang, I-T. Lee, C.-C. Lin, Y.-L. Yang, S.-F. Luo, Y. R. Kou, and L.-D. Hsiao Cigarette smoke extract induces COX-2 expression via a PKC{alpha}/c-Src/EGFR, PDGFR/PI3K/Akt/NF-{kappa}B pathway and p300 in tracheal smooth muscle cells Am J Physiol Lung Cell Mol Physiol, November 1, 2009; 297(5): L892 - L902. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Kassel, P. R. Dodmane, N. A. Schulte, and M. L. Toews Lysophosphatidic Acid Induces Rapid and Sustained Decreases in Epidermal Growth Factor Receptor Binding via Different Signaling Pathways in BEAS-2B Airway Epithelial Cells J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 809 - 817. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Kassel, N. A. Schulte, S. M. Parker, A. D. Lanik, and M. L. Toews Lysophosphatidic Acid Decreases Epidermal Growth Factor Receptor Binding in Airway Epithelial Cells J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 109 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Andric and M. Ascoli A Delayed Gonadotropin-Dependent and Growth Factor-Mediated Activation of the Extracellular Signal-Regulated Kinase 1/2 Cascade Negatively Regulates Aromatase Expression in Granulosa Cells Mol. Endocrinol., December 1, 2006; 20(12): 3308 - 3320. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhao, D. He, B. Saatian, T. Watkins, E. Wm. Spannhake, N. J. Pyne, and V. Natarajan Regulation of Lysophosphatidic Acid-induced Epidermal Growth Factor Receptor Transactivation and Interleukin-8 Secretion in Human Bronchial Epithelial Cells by Protein Kinase C{delta}, Lyn Kinase, and Matrix Metalloproteinases J. Biol. Chem., July 14, 2006; 281(28): 19501 - 19511. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Chang, D. H. Song, and M. M. Wolfe Attenuation of Peroxisome Proliferator-activated Receptor {gamma} (PPAR{gamma}) Mediates Gastrin-stimulated Colorectal Cancer Cell Proliferation J. Biol. Chem., May 26, 2006; 281(21): 14700 - 14710. [Abstract] [Full Text] [PDF] |
||||